Iovance Biotherapeutics, Inc.
IT ˙ BIT ˙ US4622601007
€3.72 ↑0.28 (8.31%)
2026-06-04
주가
SecurityIT:1IOVA / Iovance Biotherapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership81,725 shares
Latest Disclosed Value $ 286,855
Citigroup Inc ownership in 1IOVA / Iovance Biotherapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 81,725 shares of Iovance Biotherapeutics, Inc. (IT:1IOVA) valued at $258,251 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 105,540 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of -22.56% during the quarter. The current value of the position is $303,608 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (1IOVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1IOVA / Iovance Biotherapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 81,725 -23,815 -22.56 287 -0.69 0.0001
2026-02-13 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 105,540 -304,025 -74.23 288 -67.57 0.0001
2025-11-10 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 409,565 -305,286 -42.71 889 -27.75 0.0004
2025-08-11 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 714,851 176,539 32.79 1,230 -31.42 0.0006
2025-05-12 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 538,312 54,270 11.21 1,793 -49.96 0.0009
2025-02-12 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 484,042 275,278 131.86 3,582 82.70 0.0021
2024-11-12 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 208,764 70,582 51.08 1,960 76.90 0.0011
2024-08-12 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 138,182 -401,713 -74.41 1,108 -86.15 0.0007
2024-05-10 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 539,895 -214,013 -28.39 8,001 30.54 0.0053
2024-02-09 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 753,908 -183,511 -19.58 6,129 43.70 0.0043
2023-12-06 2023-09-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 937,419 310,118 49.44 4,265 -3.42 0.0032
2023-11-09 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 937,419 310,118 4,265 0.0013
2023-08-10 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 627,301 -635,344 -50.32 4,416 -42.75 0.0029
2023-05-11 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,262,645 743,295 143.12 7,715 132.49 0.0054
2023-02-09 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 519,350 -50,824 -8.91 3,319 -39.25 0.0026
2022-11-10 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 570,174 90,702 18.92 5,462 3.17 0.0039
2022-08-10 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 479,472 389,174 430.99 5,294 251.99 0.0039
2022-05-12 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 90,298 -151,661 -62.68 1,504 -67.45 0.0009
2022-02-10 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 241,959 119,208 97.11 4,620 52.63 0.0025
2021-11-10 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 122,751 -91,074 -42.59 3,027 -45.60 0.0018
2021-08-10 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 213,825 48,618 29.43 5,564 6.39 0.0033
2021-05-13 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 165,207 116,958 242.41 5,230 133.59 0.0034
2021-02-11 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 48,249 7,661 18.88 2,239 67.59 0.0013
2020-11-12 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 40,588 -240,519 -85.56 1,336 -82.69 0.0009
2020-08-12 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 281,107 159,671 131.49 7,716 112.27 0.0060
2020-05-12 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 121,436 52,597 76.41 3,635 90.71 0.0033
2020-02-12 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 68,839 -95,547 -58.12 1,906 -36.28 0.0014
2019-11-08 2019-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 164,386 47,778 40.97 2,991 4.62 0.0024
2019-08-12 2019-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 116,608 76,831 193.15 2,859 656.35 0.0023
2019-05-13 2019-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 39,777 -204,277 -83.70 378 -82.50 0.0004
2019-02-12 2018-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 244,054 218,275 846.72 2,160 647.40 0.0022
2018-11-13 2018-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 25,779 6,750 35.47 289 18.44 0.0003
2018-08-10 2018-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 19,029 870 4.79 244 -20.52 0.0002
2018-05-11 2018-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 18,159 -40,201 -68.88 307 -34.26 0.0003
2018-02-12 2017-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 58,360 54,095 1,268.35 467 1,315.15 0.0004
2017-11-13 2017-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 4,265 3,320 351.32 33 371.43 0.0000
2017-08-11 2017-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 945 -4,743 -83.39 7 -83.33 0.0000
2017-05-12 2017-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 5,688 -36,245 -86.44 42 -85.57 0.0000
2017-02-10 2016-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 41,933 27,242 185.43 291 140.50 0.0003
2016-11-10 2016-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 14,691 3,427 30.42 121 32.97 0.0001
2016-08-12 2016-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 11,264 -32,413 -74.21 91 -58.82 0.0001
2016-05-13 2016-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 43,677 23,557 117.08 221 42.58 0.0002
2016-02-12 2015-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 20,120 -354,887 -94.63 155 -92.82 0.0002
2015-11-13 2015-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 375,007 -578 -0.15 2,160 -37.28 0.0020
2015-08-13 2015-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 375,585 375,585 3,444 0.0031
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-12-06 2023-09-30 13F/A IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-09 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 0 0 n/a n/a n/a
2023-08-10 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 50,000 -44.44 352 -35.88 n/a n/a n/a
2023-05-11 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 90,000 550 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-09 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A IOVANCE BIOTHERAPEUTICS COM Put 50,000 0.00 228 -35.51 n/a n/a n/a
2023-11-09 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 50,000 228 n/a n/a n/a
2023-08-10 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 50,000 -44.44 352 -35.88 n/a n/a n/a
2023-05-11 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 90,000 550 n/a n/a n/a
2022-11-10 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-10 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 400,000 4,416 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.